In summary, the PI3K/AKT signaling pathway promotes the activation of HIF1α, which supports tumor growth and survival, while simultaneously deactivating key tumor suppressors like PTEN and p53, facilitating cancer progression and resistance to therapies. Here, HIF1A is linked to neoplasm.